Magnesium Development Company has announced FDA breakthrough device designation for its HC screw, a resorbable magnesium alloy screw for use in orthopedic fixation procedures, according to a press release.

The HC screw is designed to avoid interfering with imaging and to reduce the need for hardware removal, according to the release.

“Magnesium Development Company (MDC) was founded on the belief that a resorbable metal technology has the potential to significantly advance the treatment of patients in orthopedics. MDC is developing implants utilizing BioMagnesium 250, a patented alloy composition that contains a unique blend of magnesium and other elements, all of which are essential for healthy bone formation,” Mark Hanes, PhD, senior technical director at MDC, said in the release. “Our HC screw is an exclusive and proprietary technology that has been formulated to provide the strength and handling properties of metal during the healing process and then fully resorbs when no longer needed. The alloy's radiolucency is similar to cortical bone and thus does not produce imaging artifacts that are common with other metallic implants. Magnesium alloys have the potential to provide a significant advancement in the standard of care for orthopedics and we are proud to bring this material technology to market,” Hanes added.

Get the latest news and education delivered to your inbox

© 2022 Healio All Rights Reserved.

Get the latest news and education delivered to your inbox

© 2022 Healio All Rights Reserved.